Catalyst Pharmaceuticals, Inc.
CPRX
$24.79
$0.552.27%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -0.16% | 1.30% | -8.16% | 1.43% | 27.46% |
| Total Depreciation and Amortization | 1.29% | -0.47% | 0.00% | 0.02% | 0.07% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -122.07% | 12.27% | 879.26% | -13.42% | 114.95% |
| Change in Net Operating Assets | 61.72% | -4,288.48% | 113.42% | -258.56% | -83.20% |
| Cash from Operations | 38.39% | -54.50% | 18.74% | -15.29% | -2.74% |
| Capital Expenditure | -- | 100.00% | -- | -- | 66.02% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 100.00% | -- | -- | 66.02% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -67.63% | 162.26% | -53.83% | -20.00% | 50.43% |
| Repurchase of Common Stock | -- | 100.00% | 65.89% | -38.36% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -8.93% | -2.06% | -3.13% | 0.18% | 89.08% |
| Cash from Financing | -649.63% | 433.72% | -71.50% | -30.97% | 174.20% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -48.02% | -48.59% | 14.33% | -16.11% | 12.88% |